Odyssey Health (ODYY) Non Operating Investment Income (2024 - 2025)
Odyssey Health's (ODYY) quarterly Non Operating Investment Income came in at -$27364.0 in Q3 2025, down 144.02% year-on-year from $62166.0 in Q3 2024, and up 55.4% quarter-over-quarter from -$61357.0 in Q2 2025.
Odyssey Health (ODYY) Non Operating Investment Income (2024 - 2025) Analysis & Trends
Odyssey Health's Non Operating Investment Income history runs 2 years deep, the most recent figure standing at -$27364.0 for Q3 2025.
- On a quarterly basis, Non Operating Investment Income fell 144.02% year-over-year to -$27364.0 in Q3 2025; TTM through Apr 2026 was -$27364.0, a 92.6% increase from a year earlier, with the FY2025 full-year figure at -$459417.0, up 71.97% from the prior year.
- Non Operating Investment Income advanced to -$27364.0 in Q3 2025 per ODYY's latest filing, from -$61357.0 in the prior quarter.
- Across five years, Non Operating Investment Income topped out at $62166.0 in Q3 2024 and bottomed at -$1.3 million in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | - |
| 10 | Odyssey Health | 1.08 Mn | 782,508.17 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2025 | -27,364.00 |
| Jul 31, 2025 | -27,364.00 |
| Apr 30, 2025 | -61,357.00 |
| Apr 30, 2025 | -61,357.00 |
| Oct 31, 2024 | -370,698.00 |
| Oct 31, 2024 | -370,698.00 |
| Jul 31, 2024 | 62,166.00 |
| Jul 31, 2024 | 62,166.00 |
| Apr 30, 2024 | -367,929.00 |
| Apr 30, 2024 | -367,929.00 |
| Jan 31, 2024 | -1.33 Mn |
| Jan 31, 2024 | -1.33 Mn |